People
Adam M. Koppel is publicly listed by Bain Capital Life Sciences as Partner. Former Biogen strategy executive; trained in medicine and neuroscience. Bain Capital Life Sciences’ current own biography confirms Adam M. Koppel, MD, PhD as Partner, initially joining Bain in2003 and returning in2016 after serving as Biogen’s Executive Vice President of Corporate Development and Chief Strategy Officer. His prior work included Bain public-equity healthcare investing and McKinsey consulting. He received an MD and a neuroscience PhD from the University of Pennsylvania, an MBA from Wharton as a Palmer Scholar, and AB/AM degrees in history and science from Harvard. Synapticure’s February2022 seed announcement names Adam Koppel personally with Bain Capital as an identity qualifier. The exact middle-initial/degree/employer bridge identifies the retained Adam M. Koppel record; no separate Adam Koppel alias or Bain corporate check is created.
- Current affiliation
- Bain Capital · Partner
- Investment range
- — – —
- Sweet spot
- —
- Investments on record
- 1
Investments
Roles
Partner
Partner